About Drug Eye Africa

Drug Eye Africa reports on the medicines that reach patients across the African continent — how they are approved, how they are manufactured, how they are tested, and what happens when they fail. We publish recalls and safety alerts as regulators issue them, and we cover the regulatory, quality and industry developments that shape the medicine supply.

Who we serve

Our readers are the people who make decisions about medicines: regulatory affairs professionals, pharmacists and pharmacovigilance officers, procurement and supply chain managers, manufacturers and distributors, public health officials, researchers, and the journalists and investors who follow the sector.

What we cover

Coverage is filed under four sections, each with its own standing brief.

• Alerts & Recalls — recalls, falsified medicines, agency alerts and import holds.
• Regulatory — approvals, registrations, inspections, licensing, policy and medical devices.
• Quality & Safety — surveillance surveys, pharmacovigilance, laboratory findings and adverse reactions.
• Industry — manufacturing, clinical research, market intelligence, procurement and access.

Editorial independence

Drug Eye Africa is privately owned and editorially independent. It is not affiliated with, endorsed by, or acting on behalf of any national medicines regulator or intergovernmental body. No advertiser or funder reviews copy before publication.

Our editorial standards are set out in full in our editorial policy, and our funding and conflict-of-interest rules in our ethics and conflict of interest policy.

Corrections

We correct errors openly. Corrections and material updates are timestamped on the article itself rather than made silently, so the record of what changed remains visible. If you believe we have published something inaccurate, write to info@drugeyeafrica.com.